RhoTauPharma · 2017-01-13 · development timelines, and raises the potential for delays in...
4
Transcript of RhoTauPharma · 2017-01-13 · development timelines, and raises the potential for delays in...
![Page 1: RhoTauPharma · 2017-01-13 · development timelines, and raises the potential for delays in regulatory approval. Poorly water-soluble or hydrophobic new chemical enti- ties (NCEs)](https://reader034.fdocuments.net/reader034/viewer/2022050205/5f589ff1375130603168d60a/html5/thumbnails/1.jpg)
![Page 2: RhoTauPharma · 2017-01-13 · development timelines, and raises the potential for delays in regulatory approval. Poorly water-soluble or hydrophobic new chemical enti- ties (NCEs)](https://reader034.fdocuments.net/reader034/viewer/2022050205/5f589ff1375130603168d60a/html5/thumbnails/2.jpg)
![Page 3: RhoTauPharma · 2017-01-13 · development timelines, and raises the potential for delays in regulatory approval. Poorly water-soluble or hydrophobic new chemical enti- ties (NCEs)](https://reader034.fdocuments.net/reader034/viewer/2022050205/5f589ff1375130603168d60a/html5/thumbnails/3.jpg)
![Page 4: RhoTauPharma · 2017-01-13 · development timelines, and raises the potential for delays in regulatory approval. Poorly water-soluble or hydrophobic new chemical enti- ties (NCEs)](https://reader034.fdocuments.net/reader034/viewer/2022050205/5f589ff1375130603168d60a/html5/thumbnails/4.jpg)